Home/Asenapine in the Treatment of Negative Symptoms of Schizophrenia: Clinical Trial Design and Rationale

Asenapine in the Treatment of Negative Symptoms of Schizophrenia: Clinical Trial Design and Rationale

$30.00

Asenapine in the Treatment of Negative Symptoms of Schizophrenia: Clinical Trial Design and Rationale

By Larry Alphs, MD, PhD, John Panagides, PhD, and Scott Lancaster, MS

Want a discount? Become a member by purchasing Psychopharmacology Bulletin Subscription - Individual!

Description

Asenapine in the Treatment of Negative Symptoms of Schizophrenia: Clinical Trial Design and Rationale

By Larry Alphs, MD, PhD, John Panagides, PhD, and Scott Lancaster, MS

PB-40-2-06-Alphs